Defining Solutions
At IVI, our programs bring together stakeholders to focus on some of the most demanding questions in healthcare so we can find solutions that advance better patient outcomes.
![](https://thevalueinitiative.org/wp-content/uploads/2023/12/health-equity-export.png)
HTA Innovation
Innovation in health technologies (pharmaceutical and non-pharmaceutical) has made major contributions to improved life expectancy and quality of life in past decades…
![](https://thevalueinitiative.org/wp-content/uploads/2023/12/innovation-export.png)
Health Equity
Historically, many patient communities are underrepresented in research and have been left out of the development of measures and methods for HTA.
![](https://thevalueinitiative.org/wp-content/uploads/2023/12/economic-impact-export.png)
Economic Impact
The health economic burden on individuals in the United States is significant. Americans owe nearly $195 million in medical debt, and these financial burdens are worse for middle-aged and BIPOC individuals (Black, Indigenous, People of Color).
![](https://thevalueinitiative.org/wp-content/uploads/2023/12/rare-deseases-export.png)
Rare Diseases
More than 30 million Americans are living with rare diseases and disorders.
One study estimated the total economic burden in the US of 379 rare diseases to be $997 billion in 2019.
![](https://thevalueinitiative.org/wp-content/uploads/2023/12/hta-img1-export-1024x748.jpg)
HTA Models
The Open-Source Value Project is a laboratory for advancing the science and improving the practice of value assessment in the U.S.
RESOURCES
A research-based plan for putting the principle of patient-centricity into practice